CLINICAL_TRIALS
trial_result
· 2025-07-14
Clinical Trial Update: Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only) [Phase 3]
Summary
A Phase 3 trial evaluating the efficacy and safety of rimegepant for migraine prevention in Japanese subjects has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2025-07-14